From 1 to 3 September 2026, the 20th Medtec China — International Medical Device Design and Manufacturing Technology Exhibition — took place at the Shanghai New International Expo Centre. Suzhou DRUTEK exhibited in Hall N1 alongside more than 1,100 exhibitors from close to 27 countries, and spent three days meeting existing customers, overseas buyers and industry partners.
It was our second consecutive year at Medtec. What changed this year was not the number of visitors but the nature of the questions: customers used to open with "can you make this", and now they open with "where is your process evidence".
Medtec covers the upstream of medical device development and manufacturing. The people who walk it are mostly R&D, process, quality, regulatory and purchasing staff from device makers — few are there for a casual look. What we brought was the full medical PCBA manufacturing capability:
The most frequent questions over the three days were not about equipment models but three very practical ones: how lead time is protected in small-batch, multi-variety work; how much process validation has to be repeated when a design changes; and whether traceability granularity from prototype to volume can line up with the customer's DHR. There are no textbook answers — you can only answer with real data from the line. A quotation cannot show any of it; only people who stand at the line every day can.
On the first morning we completed the selection and signing for the 2027 stand, at twice this year's area. It was a quick decision for a simple reason: two bays were no longer enough to handle the traffic, and medical electronics demand in China is still climbing.
Two trends were visible on the floor. First, active devices such as surgical robots and brain-computer interfaces are moving from "possible" to "usable and widely adopted", and volume ramp-up brings simultaneous requirements on materials, key components and manufacturing process. Second, device makers are shifting their supply-chain requirement from "can deliver" to "can prove" — system documentation, process data and traceability records are becoming an entry condition rather than a bonus.
For a manufacturing partner this changes the basis of competition: it is no longer who quotes lower, but who can build a complete and verifiable compliance evidence chain.
Medical electronics has been one of our core industries since DRUTEK was founded in 2020. We currently hold ISO 9001, ISO 13485, IATF 16949 and ANSI/ESD S20.20 certification. In medical products the cost of failure is not in the board but in the recall, which is why our requirements on first-article verification, process parameter locking and batch traceability are far stricter than in consumer work — the detail is written up in Medical PCBA Quality Control: From ISO 13485 to First-Article Verification.
Thank you to every customer and partner who visited us in Hall N1, and to the colleagues who left Suzhou early and stood on the stand for three straight days. In 2027: a larger stand, a more complete offer. See you in Shanghai.
